A detailed history of American Century Companies Inc transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 9,298 shares of KYMR stock, worth $400,371. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,298
Previous 10,847 14.28%
Holding current value
$400,371
Previous $323,000 36.22%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$30.16 - $52.4 $46,717 - $81,167
-1,549 Reduced 14.28%
9,298 $440,000
Q2 2024

Aug 07, 2024

SELL
$29.85 - $39.42 $1.1 Million - $1.45 Million
-36,820 Reduced 77.24%
10,847 $323,000
Q1 2024

May 14, 2024

BUY
$22.9 - $43.57 $570,049 - $1.08 Million
24,893 Added 109.3%
47,667 $1.92 Million
Q4 2023

Feb 13, 2024

BUY
$10.97 - $26.84 $249,830 - $611,254
22,774 New
22,774 $579,000
Q3 2023

Nov 13, 2023

BUY
$13.9 - $23.88 $1.72 Million - $2.96 Million
124,005 Added 112.17%
234,558 $3.26 Million
Q2 2023

Aug 14, 2023

SELL
$22.4 - $34.92 $100,553 - $156,755
-4,489 Reduced 3.9%
110,553 $2.54 Million
Q1 2023

May 11, 2023

BUY
$24.84 - $38.75 $107,507 - $167,710
4,328 Added 3.91%
115,042 $3.41 Million
Q4 2022

Feb 13, 2023

SELL
$19.57 - $30.92 $2.3 Million - $3.63 Million
-117,496 Reduced 51.49%
110,714 $2.76 Million
Q3 2022

Nov 14, 2022

BUY
$20.91 - $34.27 $28,249 - $46,298
1,351 Added 0.6%
228,210 $4.97 Million
Q2 2022

Aug 12, 2022

BUY
$14.13 - $42.55 $196,392 - $591,402
13,899 Added 6.53%
226,859 $4.47 Million
Q1 2022

May 11, 2022

BUY
$35.3 - $64.68 $915,434 - $1.68 Million
25,933 Added 13.87%
212,960 $9.01 Million
Q4 2021

Feb 07, 2022

BUY
$49.91 - $65.56 $1.81 Million - $2.38 Million
36,281 Added 24.07%
187,027 $11.9 Million
Q3 2021

Nov 10, 2021

BUY
$47.8 - $66.66 $2,485 - $3,466
52 Added 0.03%
150,746 $8.86 Million
Q2 2021

Aug 05, 2021

BUY
$31.08 - $51.95 $11,250 - $18,805
362 Added 0.24%
150,694 $7.31 Million
Q1 2021

May 14, 2021

SELL
$35.64 - $85.46 $44,300 - $106,226
-1,243 Reduced 0.82%
150,332 $5.84 Million
Q4 2020

Feb 12, 2021

SELL
$28.07 - $87.83 $5,557 - $17,390
-198 Reduced 0.13%
151,575 $9.4 Million
Q3 2020

Nov 13, 2020

BUY
$26.1 - $33.28 $3.96 Million - $5.05 Million
151,773 New
151,773 $4.9 Million

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.36B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.